Literature DB >> 26468219

Hypertriglyceridaemia unresponsive to multiple treatments.

James M Backes1, Thomas D Dayspring2, Daniel M Hoefner3, Patrick M Moriarty4.   

Abstract

A 52-year-old man with a longstanding history of hypertriglyceridaemia (approximately 7 mmol/L (600 mg/dL)), unresponsive to treatment, presented to a lipid-specialty clinic. Additional triglyceride-lowering therapies were added with no effect. It was then noted that despite the apparent hypertriglyceridaemia, his serum sample was clear. A 'glycerol blank' was then requested from an advanced lipid laboratory, which reported a triglyceride value of 0.7 mmol/L (62 mg/dL). These findings suggest isolated asymptomatic glycerol kinase deficiency (GKD) or 'pseudohypertriglyceridaemia'. The falsely elevated triglyceride values in such individuals are a result of excess serum glycerol and clinical laboratories measuring glycerol to report triglyceride concentrations. After discontinuation or modification of the patient's primary triglyceride-lowering agents, the lipid panels and triglyceride values remained comparable to previous readings. Recognition of asymptomatic GKD is important to prevent unnecessary treatment and overestimated cardiovascular risk. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26468219      PMCID: PMC4612542          DOI: 10.1136/bcr-2015-210788

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Glycerol blanking in triglyceride assays: is it necessary?

Authors:  T G Cole
Journal:  Clin Chem       Date:  1990-07       Impact factor: 8.327

2.  Pseudohypertriglyceridemia--verifying the hypertriglyceridemic patient.

Authors:  James M Backes; Thomas Dayspring; Patrick M Moriarty
Journal:  J Clin Lipidol       Date:  2012-09-18       Impact factor: 4.766

3.  Glycerol as a correlate of impaired glucose tolerance: dissection of a complex system by use of a simple genetic trait.

Authors:  D Gaudet; S Arsenault; L Pérusse; M C Vohl; J St-Pierre; J Bergeron; J P Després; K Dewar; M J Daly; T Hudson; J D Rioux
Journal:  Am J Hum Genet       Date:  2000-03-27       Impact factor: 11.025

Review 4.  Isolated and contiguous glycerol kinase gene disorders: a review.

Authors:  D R Sjarif; J K Ploos van Amstel; M Duran; F A Beemer; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

Review 5.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

6.  Pseudohypertriglyceridemia: two cases of probable glycerol kinase deficiency.

Authors:  James M Backes; Thomas Dayspring; Thomas Mieras; Patrick M Moriarty
Journal:  J Clin Lipidol       Date:  2012-02-08       Impact factor: 4.766

7.  Decreased stability of triglycerides and increased free glycerol in serum from heparin-treated patients.

Authors:  G L Hortin; T G Cole; D W Gibson; G Kessler
Journal:  Clin Chem       Date:  1988-09       Impact factor: 8.327

8.  Familial hyperglycerolemia.

Authors:  C I Rose; D S Haines
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

9.  Glycerol metabolism and the determination of triglycerides--clinical, biochemical and molecular findings in six subjects.

Authors:  Christina Hellerud; Alberto Burlina; Carlo Gabelli; James R Ellis; Per-Georg Nyholm; Sven Lindstedt
Journal:  Clin Chem Lab Med       Date:  2003-01       Impact factor: 3.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.